| 17.17 Delayed Data As of Oct 11 |  -0.10 / -0.58%Today’s Change | 16.47 Today|||52-Week Range 39.68 | -25.64% Year-to-Date |
| Top Ranked Momentum Stocks to Buy for September 16th Sep 16 / Zacks.com - Paid Partner Content |
| Previous close | 17.27 |
| Today’s open | 17.27 |
| Day’s range | 17.00 - 17.54 |
| Volume | 116,475 |
| Average volume (3 months) | 320,742 |
| Market cap | $2.3B |
| Earnings growth (last year) | -160.83% |
| Earnings growth (this year) | -53.68% |
| Earnings growth (next 5 years) | +7.15% |
| Revenue growth (last year) | -11.61% |
| P/E ratio | 10.8 |
| Price/Sales | 14.34 |
| Price/Book | 5.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| BHVNBiohaven Pharmaceuti... | +1.30 | +3.12% |
| ARNAArena Pharmaceutical... | +0.66 | +1.42% |
| RARXRa Pharmaceuticals I... | +0.90 | +1.97% |
| PTCTPTC Therapeutics Inc | +0.91 | +2.65% |
| Next reporting date | November 15, 2019 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $213.9M |
| Annual profit (last year) | -$74.7M |
| Net profit margin | -34.94% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Christian Hogg |
Vice President & Head-International Operations Enrico Magnanelli |
Corporate headquarters Hong Kong, -- |
